CAS 1558036-85-3

Fórmula: C24H25N5O3

InChI: InChI=1S/C24H25N5O3/c1-2-20(30)28-14-6-7-17(15-28)29-23(25)21(24(26)31)22(27-29)16-10-12-19(13-11-16)32-18-8-4-3-5-9-18/h2-5,8-13,17H,1,6-7,14-15,25H2,(H2,26,31)/t17-/m1/s1

Chave InChI: WTLRSSATGYETCG-QGZVFWFLSA-N

SMILES: C=CC(=O)N1CCC[C@H](C1)N2C(=C(C(=N2)C3=CC=C(C=C3)OC4=CC=CC=C4)C(=O)N)N

Btk inhibitor 2

CAS: 1558036-85-3

Btk inhibitor 2 (BGB-3111 analog) is a BTK inhibitor.

Fórmula: C₂₄H₂₅N₅O₃

Pureza: 99.94%

Cor e Forma: Solid

Peso molecular: 431.487

Ref: TM-T10629

Btk inhibitor 2

CAS: 1558036-85-3

Btk inhibitor 2

Fórmula: C₂₄H₂₅N₅O₃

Pureza: ≥98%

Peso molecular: 431.49

Ref: 54-BUP02415

Btk inhibitor 2

CAS: 1558036-85-3

Fórmula: C₂₄H₂₅N₅O₃

Pureza: 98%

Peso molecular: 431.4870

Ref: IN-DA01EO8J

Btk inhibitor 2

CAS: 1558036-85-3

Btk inhibitor 2 is a protein kinase inhibitor that was developed to target the B-cell lymphoma tumor necrosis factor receptor. It binds to the ATP binding site of Btk and prevents activation of the kinase. This drug has been shown to be effective in treating cancer by inhibiting cancer-related genes and promoting apoptosis in cancer cells. The drug has also been shown to have an effect on skeletal muscle, with a dose-dependent response for increasing muscle mass and decreasing fat content.

Fórmula: C₂₄H₂₅N₅O₃

Pureza: Min. 95%

Peso molecular: 431.49 g/mol

Ref: 3D-IMC03685